Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Ontario Clinical Oncology Group (OCOG) Hoffmann-La Roche |
---|---|
Information provided by: | Ontario Clinical Oncology Group (OCOG) |
ClinicalTrials.gov Identifier: | NCT00391248 |
To improve the clinical outcomes of patients with non-small cell lung cancer treated with radiation therapy.
Condition | Intervention | Phase |
---|---|---|
Non-Small Cell Lung Cancer |
Drug: Erlotinib |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety/Efficacy Study |
Official Title: | A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Patients With Non-Small Cell Carcinoma of the Lung. (PEARL Trial) |
Estimated Enrollment: | 45 |
Study Start Date: | November 2006 |
Estimated Study Completion Date: | March 2010 |
Estimated Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jolanta Windsor | 905-527-2299 ext 42618 | windsor@mcmaster.ca |
Canada, Ontario | |
Juravinski Cancer Centre | Recruiting |
Hamilton, Ontario, Canada, L8V 1C3 | |
Contact: Jim Wright, MD 905-387-9495 ext 64706 jim.wright@hrcc.on.ca | |
Principal Investigator: Jim Wright, MD | |
Toronto Sunnybrook Regional Cancer Centre | Recruiting |
Toronto, Ontario, Canada, M5N 3M5 | |
Contact: Yee Ung, MD 416-480-4951 yee.ung@sunnybrook.ca | |
Principal Investigator: Yee Ung, MD |
Principal Investigator: | Jim Wright, MD | Juravinski Cancer Centre |
Responsible Party: | Ontario Clinical Oncology Group (OCOG) ( Dr. Mark Levine/Director OCOG ) |
Study ID Numbers: | CTA-Control-105472 |
Study First Received: | October 19, 2006 |
Last Updated: | November 17, 2008 |
ClinicalTrials.gov Identifier: | NCT00391248 History of Changes |
Health Authority: | Canada: Health Canada |
non-small cell lung cancer palliative radiation tarceva palliative thoracic radiation therapy |
Erlotinib Thoracic Neoplasms Respiratory Tract Diseases Lung Neoplasms Lung Diseases |
Non-small Cell Lung Cancer Protein Kinase Inhibitors Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial Carcinoma |
Thoracic Neoplasms Erlotinib Respiratory Tract Neoplasms Neoplasms by Histologic Type Molecular Mechanisms of Pharmacological Action Enzyme Inhibitors Protein Kinase Inhibitors Pharmacologic Actions |
Carcinoma Neoplasms Neoplasms by Site Respiratory Tract Diseases Lung Neoplasms Lung Diseases Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial |